Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
19
-
Total shares
-
1.1M
-
Shares change
-
-50K
-
Total reported value, excl. options
-
$1.9M
-
Value change
-
-$90.6K
-
Number of buys
-
6
-
Number of sells
-
-7
-
Price
-
$1.75
Significant Holders of HCW Biologics Inc. - COM (HCWB) as of Q1 2024
19 filings reported holding HCWB - HCW Biologics Inc. - COM as of Q1 2024.
HCW Biologics Inc. - COM (HCWB) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.1M shares
.
Largest 10 shareholders include HighTower Advisors, LLC (180K shares), Avantax Planning Partners, Inc. (180K shares), GEODE CAPITAL MANAGEMENT, LLC (174K shares), Cresset Asset Management, LLC (132K shares), Pullen Investment Management, LLC (85.1K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (84.7K shares), HRT FINANCIAL LP (73.1K shares), BlackRock Inc. (46K shares), VANGUARD GROUP INC (37.6K shares), and AE Wealth Management LLC (30K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.